Skip to content

Knotless Suture in Revision Total Joint Arthroplasty

Knotless Suture in Revision Total Joint Arthroplasty: A Prospective Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04403919
Enrollment
81
Registered
2020-05-27
Start date
2020-09-01
Completion date
2023-06-01
Last updated
2024-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroplasty

Brief summary

Barbed suture has been demonstrated to be safe in primary hip and knee surgery and retrospective data suggests barbed suture represents no increased complications in the revision setting. Barbed suture may represent a faster, more effective way to perform revision arthroplasty closures. There are no Level I studies comparing traditional and barbed suture closure. The purpose of this study is to assess the surgical complexities of closures using closure time without sacrificing cosmesis or wound complications between the traditional closure and barbed closure.

Interventions

DEVICEConventional Closure: Knee

Traditional closure will consist of arthrotomy (deep layer) closed with figure of eight number 1 vicryl plus followed by closure of the intermediate layer with 0 Vicryl plus. The intermediate layer will be performed at surgeon's discretion especially in thin patients. Subdermal layer with 2-0 vicryl suture followed by subcuticular 3-0 monofilament suture (monocryl PLUS, Ethicon; Johnson & Johnson) and Dermabond advanced.

DEVICEBarbed suture closure: Knee

The barbed suture closure will consist of number 2 Stratafix symmetric PDS PLUS for the arthrotomy, intermediate layer will be performed at surgeon's discretion in thin patients, if performed will entail stratafix spiral, subdermal 2-0 stratafix spiral monocryl plus. Followed by subcuticular 3-0 stratafix spiral monocryl plus suture and Dermabond advance.

DEVICEConventional Closure: Hip

1. The capsule will be closed with Vicryl Plus number 1 2. Deep fascia with figure of eight interrupted number 1 braided absorbable suture (Vicryl plus, Ethicon; Johnson &Johnson, Somerville, NJ) 3. Subdermal fat layer simple interrupted knots using number 2-0 braided absorbable sutures (Vicryl plus) 4. Subcuticular 3-0 monofilament suture (monocryl plus , Ethicon; Johnson & Johnson) 5. followed by the use of skin adhesive (Dermabond Advanced, Ethicon; Johnson &Johnson).

DEVICEBarbed suture closure: Hip

1. The capsule will be closed with stratafix symmetric PDS Plus 2. Deep fascia will be closed with Stratafix Symmetric PDS Plus (Stratafix symmetric PDS plus, Ethicon; Johnson &Johnson, Somerville, NJ) 3. Subdermal layer with running number 2-0 barbed suture (stratafix spiral monocryl plus, Ethicon; Johnson & Johnson, Somerville, NJ) 4. Subcuticular suture with stratafix spiral monocryl plus, Ethicon 5. followed by the use of skin adhesive (Dermabond advanced, Ethicon; Johnson &Johnson).

Sponsors

NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Intervention model description

prospective, randomized, controlled trial, parallel four-arm design, single-center study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patients ≥ 18 years of age 2. Surgical candidates undergoing revision total knee or total hip arthroplasty for one of the following indications second stage of two stage reimplantation for infection, mechanical loosening, instability, polyethylene wear, stiffness, or periprosthetic fracture

Exclusion criteria

1. Patient is ≤ 18 years of age 2. Patient is unable to provide written consent 3. Patient has active infections in the operative leg/joint 4. Known Allergy to Suture material 5. Underlying Dermatological diseases affecting surgical site including dermatitis, eczema, or psoriasis; connective tissue or vascular disorders or diseases that would adversely affect wound healing; metastatic cancer; renal insufficiency (dialysis); steroid dependence; malnourishment; and other disease processes resulting in an immunocompromised state. Diabetes, smoking and obesity will be allowed as they are frequent comorbidities in our revision joint population 6. Anterior total hip replacement 7. Stage 1 of two stage revision for infection 8. Closure performed by plastic surgeon, including flap coverage Vulnerable populations will not be enrolled in this study. Withdrawal Criteria 1. Failure to attend regularly scheduled follow up appointments 2. Deviation from closure protocol

Design outcomes

Primary

MeasureTime frameDescription
Time of Closure in MinutesUp to a maximum of 66 minutes (perioperative)Measurement of the time needed to properly close the wound with each technique.

Secondary

MeasureTime frameDescription
Incidence of Complications Related to Wound ClosureDay 90Number of all complications (including needle sticks and glove perforations) and infections related to the wound closure.
Patient and Observer Scar Assessment Scale (POSAS) ScoreWeek 6 Post-SurgeryThe POSAS consists of two parts: a Patient Scale and an Observer Scale. Both scales contain six items that are scored numerically on a ten-step scale, where 0 = normal skin and 10 = worst scar imaginable. Together they make up the 'Total Score' of the Patient and Observer Scale, which ranges from 0 to 120; higher scores indicate worse scars.
Mean Number of Sutures Used45 minutes (perioperative)
Mean Length of Incision30 minutes (perioperative)

Countries

United States

Participant flow

Participants by arm

ArmCount
Revision Total Knee Arthroplasty: Control
Conventional Closure: Knee: Traditional closure will consist of arthrotomy (deep layer) closed with figure of eight number 1 vicryl plus followed by closure of the intermediate layer with 0 Vicryl plus. The intermediate layer will be performed at surgeon's discretion especially in thin patients. Subdermal layer with 2-0 vicryl suture followed by subcuticular 3-0 monofilament suture (monocryl PLUS, Ethicon; Johnson & Johnson) and Dermabond advanced.
22
Revision Total Knee Arthroplasty: Active
Barbed suture closure: Knee: The barbed suture closure will consist of number 2 Stratafix symmetric PDS PLUS for the arthrotomy, intermediate layer will be performed at surgeon's discretion in thin patients, if performed will entail stratafix spiral, subdermal 2-0 stratafix spiral monocryl plus. Followed by subcuticular 3-0 stratafix spiral monocryl plus suture and Dermabond advance.
30
Revision Total Hip Arthroplasty: Control
Conventional Closure: Hip: 1. The capsule will be closed with Vicryl Plus number 1 2. Deep fascia with figure of eight interrupted number 1 braided absorbable suture (Vicryl plus, Ethicon; Johnson &Johnson, Somerville, NJ) 3. Subdermal fat layer simple interrupted knots using number 2-0 braided absorbable sutures (Vicryl plus) 4. Subcuticular 3-0 monofilament suture (monocryl plus , Ethicon; Johnson & Johnson) 5. followed by the use of skin adhesive (Dermabond Advanced, Ethicon; Johnson &Johnson).
18
Revision Total Hip Arthroplasty: Active
Barbed suture closure: Hip: 1. The capsule will be closed with stratafix symmetric PDS Plus 2. Deep fascia will be closed with Stratafix Symmetric PDS Plus (Stratafix symmetric PDS plus, Ethicon; Johnson &Johnson, Somerville, NJ) 3. Subdermal layer with running number 2-0 barbed suture (stratafix spiral monocryl plus, Ethicon; Johnson & Johnson, Somerville, NJ) 4. Subcuticular suture with stratafix spiral monocryl plus, Ethicon 5. followed by the use of skin adhesive (Dermabond advanced, Ethicon; Johnson &Johnson).
10
Total80

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003
Overall StudyLost to Follow-up0001

Baseline characteristics

CharacteristicRevision Total Knee Arthroplasty: ControlTotalRevision Total Hip Arthroplasty: ActiveRevision Total Hip Arthroplasty: ControlRevision Total Knee Arthroplasty: Active
Age, Continuous64.3 years63.4 years64.9 years61.7 years63.3 years
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
5 Participants18 Participants0 Participants4 Participants9 Participants
Race (NIH/OMB)
More than one race
4 Participants20 Participants2 Participants3 Participants11 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants1 Participants0 Participants1 Participants0 Participants
Race (NIH/OMB)
White
13 Participants41 Participants8 Participants10 Participants10 Participants
Region of Enrollment
United States
22 participants80 participants10 participants18 participants30 participants
Sex: Female, Male
Female
16 Participants53 Participants5 Participants14 Participants18 Participants
Sex: Female, Male
Male
6 Participants27 Participants5 Participants4 Participants12 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 220 / 300 / 180 / 11
other
Total, other adverse events
1 / 222 / 301 / 181 / 11
serious
Total, serious adverse events
1 / 222 / 300 / 180 / 11

Outcome results

Primary

Time of Closure in Minutes

Measurement of the time needed to properly close the wound with each technique.

Time frame: Up to a maximum of 66 minutes (perioperative)

ArmMeasureValue (MEAN)
Revision Total KNEE Arthroplasty: Control (Conventional Closure)Time of Closure in Minutes36.3 minutes
Revision Total KNEE Arthroplasty: Active (Barbed Suture Closure)Time of Closure in Minutes31.1 minutes
Revision Total HIP Arthroplasty: Control (Conventional Closure)Time of Closure in Minutes35.9 minutes
Revision Total HIP Arthroplasty: Active (Barbed Suture Closure)Time of Closure in Minutes27.1 minutes
Secondary

Incidence of Complications Related to Wound Closure

Number of all complications (including needle sticks and glove perforations) and infections related to the wound closure.

Time frame: Day 90

ArmMeasureValue (NUMBER)
Revision Total KNEE Arthroplasty: Control (Conventional Closure)Incidence of Complications Related to Wound Closure2 Total number of complications
Revision Total KNEE Arthroplasty: Active (Barbed Suture Closure)Incidence of Complications Related to Wound Closure4 Total number of complications
Revision Total HIP Arthroplasty: Control (Conventional Closure)Incidence of Complications Related to Wound Closure1 Total number of complications
Revision Total HIP Arthroplasty: Active (Barbed Suture Closure)Incidence of Complications Related to Wound Closure0 Total number of complications
Secondary

Mean Length of Incision

Time frame: 30 minutes (perioperative)

ArmMeasureValue (MEAN)
Revision Total KNEE Arthroplasty: Control (Conventional Closure)Mean Length of Incision196.4 millimeters
Revision Total KNEE Arthroplasty: Active (Barbed Suture Closure)Mean Length of Incision186 millimeters
Revision Total HIP Arthroplasty: Control (Conventional Closure)Mean Length of Incision168 millimeters
Revision Total HIP Arthroplasty: Active (Barbed Suture Closure)Mean Length of Incision177 millimeters
Secondary

Mean Number of Sutures Used

Time frame: 45 minutes (perioperative)

ArmMeasureValue (MEAN)
Revision Total KNEE Arthroplasty: Control (Conventional Closure)Mean Number of Sutures Used10.9 sutures
Revision Total KNEE Arthroplasty: Active (Barbed Suture Closure)Mean Number of Sutures Used6.3 sutures
Revision Total HIP Arthroplasty: Control (Conventional Closure)Mean Number of Sutures Used9.1 sutures
Revision Total HIP Arthroplasty: Active (Barbed Suture Closure)Mean Number of Sutures Used5.9 sutures
Secondary

Patient and Observer Scar Assessment Scale (POSAS) Score

The POSAS consists of two parts: a Patient Scale and an Observer Scale. Both scales contain six items that are scored numerically on a ten-step scale, where 0 = normal skin and 10 = worst scar imaginable. Together they make up the 'Total Score' of the Patient and Observer Scale, which ranges from 0 to 120; higher scores indicate worse scars.

Time frame: Week 6 Post-Surgery

ArmMeasureValue (MEAN)
Revision Total KNEE Arthroplasty: Control (Conventional Closure)Patient and Observer Scar Assessment Scale (POSAS) Score2.7 score on a scale
Revision Total KNEE Arthroplasty: Active (Barbed Suture Closure)Patient and Observer Scar Assessment Scale (POSAS) Score3.4 score on a scale
Revision Total HIP Arthroplasty: Control (Conventional Closure)Patient and Observer Scar Assessment Scale (POSAS) Score2.5 score on a scale
Revision Total HIP Arthroplasty: Active (Barbed Suture Closure)Patient and Observer Scar Assessment Scale (POSAS) Score2.6 score on a scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026